Interest of EMDR Schizophrenic Disorders

NCT05164289 | Terminated

• 1 other identifier: CHRD 1721
• Study Type: observational
• Target: 6
• Locations: 1 country
• Sites: 2

Brief Summary

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

Conditions

Schizophrenic Disorders

Keywords

Schizophrenic disorders; Psychosis; Eye Movement Desensitization and Reprocessing

Outcome Measures

Primary Outcomes (1)

• Assessment of the decrease in the severity of positive or negative symptoms of schizophrenia

  The decrease in the severity of positive or negative symptoms of schizophrenia is assessed using the "Positive and Negative Syndrome Scale" (PANSS) between M0 and M6.This decrease will be considered effective if it's greater than or equal to 20%.

  At 6 month after Hospital discharge (M0)

Secondary Outcomes (3)

• Assessment of the decrease in the intensity of dissociative symptoms.

  At 6 month after Hospital discharge (M0)

• Assessment of the decrease in the intensity of anxiety and depressive symptoms.

  At 6 month after Hospital discharge (M0)

• Quality of life assessment

  At 6 month after Hospital discharge (M0)

Study Arms (2)

Control group

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

Other: Control group

EMDR group

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

Other: EMDR group

Interventions

Control group OTHER

Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75

Control group

EMDR group OTHER

Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75

EMDR group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized for decompensated psychotic disorder in the psychiatric departments of the Centers Hospitaliers of Pontoise or Villejuif.

You may qualify if:

• ≥ 18 years and over,
• Hospitalized for decompensated psychotic disorder, Positive diagnosis of schizophrenia or schizoaffective disorder (according to the DSM-V psychiatry manual),
• With positive or negative symptoms according to the Positive and Negative Syndrome Scale (PANSS),
• Stabilized clinical condition (considered compatible with hospital discharge),
• With ambulatory follow-up planned after hospitalization

You may not qualify if:

• \< 18 years,
• Patients who do not meet the diagnostic criteria (according to the DSM-V psychiatry manual) for schizophrenic or schizoaffective disorder),
• Non-French speaking or illiterate patients,
• Cognitive disorders making it impossible the understanding and the none- opposition to the study,
• Non-stabilized clinical condition (incompatible with hospital discharge),

Sponsors & Collaborators

• Hôpital NOVO: lead

Study Sites (2)

Departement of Psychiatry - Hospital René Dubos

Pontoise, 95300, France

Location

Departement of Psychiatry -Hospital Paul Guiraud

Villejuif, 94800, France

Location

MeSH Terms

Conditions

Schizophrenia; Psychotic Disorders

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Officials

• Dr Marie-Claire ASMAR

  Hospital René Dubos - Pontoise

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 6 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 6, 2021
• First Posted: December 20, 2021
• Study Start: December 10, 2021
• Primary Completion: April 27, 2022
• Study Completion: April 27, 2022
• Last Updated: September 19, 2024

Record last verified: 2022-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)